PTSM: Pharmaceutical Technology Sourcing and Management, Jun 22, 2007 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jun 22, 2007
Global Feature
Opportunities Abound for Generic Drugs
By Patricia Van Arnum
Double-digit growth is projected for the US generic drug market, and the industry positions for opportunities in biosimilars.
Pharma Partner Focus
Pfizer CentreSource Moves Forward with Asian Supply Pact
By Patricia Van Arnum
Pfizer CentreSource is proceeding with a new plan for the supply of steroids and steroid intermediates through a recently signed pact with two Asian contract manufacturing organizations.
Outsourcing
Is Your Company Lucky or Smart?
By Jim Miller
While some companies float with the tide, others grab market share while business is good.
News
Mergers, acquisitions, and restructuring
A roundup of company moves and positioning from the pharmaceutical industry and biotechnology industries, and contract service providers.
Expansions
A roundup of manufacturing and service expansions.
Agreements and contracts
The latest pacts from the pharmaceutical supply chain.
People
People on the move.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here